W
alking is an important determinant of disability and quality of life in people with Parkinson disease (PD). 1 Results from a recent longitudinal study in PD revealed steeper trajectories of decline in gait speed and gait-related balance over a 2-year period compared with other activity level measures, suggesting the importance of gait decline as a marker of disability. 2 A substantial decline in the amount of walking has also been reported in PD, even early in the course of the disease. [3] [4] [5] In comparison to healthy age-matched controls, persons with PD have been described as approximately one-third less active. 6 A decline in step counts, measured by a research grade activity monitor, has been shown to precede worsening of motor symptoms and limitations in gait-related activities including grocery shopping, housework, yardwork, and socializing in the community. 1, 5 Collectively, this data suggests that increasing natural ambulatory behavior may be an important target of intervention to reduce disability and optimize participation in preferred activities.
With advances in sensor-based technology, wearable consumer-grade activity trackers have become widely available as a means of monitoring step counts. In general, activity trackers provide a means of goal setting and self-monitoring of walking behavior while providing feedback and rewards with the goal of changing behavior (ie, increasing amount of walking). Persons with neurodegenerative conditions, such as PD, may benefit from wearing an activity tracker given the importance of walking as a marker of disability and a target of intervention. Activity trackers are devices worn on the body that utilize various types of sensors (eg, accelerometers, gyroscopes, altimeters) to determine number of steps walked. There are numerous types of activity trackers, each with proprietary algorithms designed for step counting. The algorithms have been developed to detect motion patterns that represent typical walking behavior. The algorithms determine whether the characteristics of a motion exceed a particular threshold and can be counted as a step. 7, 8 The accuracy of a variety of consumer-grade devices has been studied primarily in healthy populations. The amount of agreement between actual steps taken and the number of steps recorded varied depending on the model of activity tracker and type of task. In prior studies, tasks were considered continuous if walking occurred on a treadmill or on a course that did not involve stopping or obstacle negotiation. A course was considered discontinuous if it occurred in a free-living environment where the environmental context varied or within a specified course that encompassed stopping or obstacle negotiation. Intraclass correlation coefficients (ICCs) ranged from 0.8 to 0.99 when tested in laboratory based continuous courses and in free-living courses that include discontinuous walking. [9] [10] [11] [12] Devices produced by Jawbone (San Francisco, California; now entered into liquidation) and Fitbit (Fitbit, San Francisco, California), 2 manufacturers that had a large market share, have been most widely studied. A recent systematic review of 22 studies in healthy adults investigating the accuracy of Fitbit and Jawbone devices reported ICCs of 0.8 or higher when tested in laboratory-based studies with continuous walking protocols. 11 In free-living settings where discontinuous walking is encompassed, similar results were found with correlation coefficients exceeding 0.9. 11 The accuracy of the Fitbit Zip device has been studied in community-dwelling older adults with ICCs of 0.88 for the 2-minute walk test and 0.94 for freeliving protocols, which included discontinuous walking over 7 days. 12 There is a paucity of research investigating the accuracy of consumer-grade activity trackers in individuals with neurologic gait disorders. Among individuals with stroke and traumatic brain injury, consumer-grade activity trackers were found to have lower accuracy in laboratory-based studies compared with similar studies in healthy populations, especially when balance impairments were present or speed was slow. 13, 14 Consumer-grade activity trackers are designed to track steps in healthy people with consistent and symmetrical gait pattern. 11 Given the atypical gait characteristics in PD (decreased step length, slow gait speed, bradykinesia, dyskinesia, asymmetric arm and leg swing), the accuracy of consumer-grade activity trackers may be compromised. 15 In order for physical therapists to make informed decisions about the potential utility of activity trackers to monitor the amount of walking in persons with PD, it is critical to investigate the accuracy of activity trackers in this population. Therefore, the purpose of this study was to investigate the accuracy of 4 commonly used consumer-grade activity trackers (Fitbit Zip, Fitbit Surge, Jawbone Up Move, Jawbone Up 2) in individuals with PD in a variety of different walking environments. We hypothesized that the accuracy may differ among the various types of activity trackers, given the differences in sensors and algorithms inherent among the various devices. We also hypothesized that location worn (waist vs wrist) and type of walking tasks (continuous vs discontinuous) would influence the accuracy of the devices in individuals with PD.
Methods

Participants
Participants were recruited from Boston University, Center for Neurorehabilitation. Inclusion criteria were idiopathic PD (using UK Brain Bank criteria), 16 score of ≥22 on the Montreal Cognitive Assessment, 17 ability to walk pain free for 10 minutes independently without an assistive device, and ability to effectively communicate with research personnel. Exclusion criteria included a diagnosis of atypical PD or a serious neurological disorder other than PD, falling an average of ≥1 fall per day over the past week, or a syncopal event when rising from sitting to standing or while ambulating over the past 6 months. All participants provided informed consent and the study was approved by the institutional review board at Boston University.
Instruments
Four models of commercially available activity trackers were used: Fitbit Zip, Fitbit Surge, Jawbone Up 2, and Jawbone Up Move. The Fitbit Surge and the Jawbone Up 2 are designed to be worn on the wrist; whereas the Fitbit Zip and the Jawbone Up Move are designed to be worn on the waist or trunk (Fig. 1) . The Fitbit Surge contains an altimeter as well as a triaxial accelerometer and tri-axial gyroscope. The Jawbone Up 2, the Jawbone Up Move, and the Fitbit Zip all contain triaxial accelerometers. All algorithms used to calculate steps for the activity trackers are proprietary and not available to the public.
Procedure
All study procedures took place during 1 session held at Boston University, Center for Neurorehabilitation, for a duration of approximately 2 hours. To characterize the sample, data on age, sex, years since diagnosis of PD, use of an assistive device, falls in the past month, and BMI were collected. The Movement Disorders Society Unified Parkinson Disease Rating Scale (part III), 18 Hoehn and Yahr classification, 19 Freezing of Gait Questionnaire, 20 Montreal Cognitive Assessment, 17 and 10-m walk test at a comfortable walking speed were administered. 21 Participants performed continuous walking consisting of two 2-minute walk tests. The course was a continuous rectangle with a perimeter of 92 meters containing four 90° turns. 22 Participants walked in a continuous fashion, with no stopping or pausing. Though the rectangle course contained 90° turns, the width of the path was sufficiently wide to allow arc-like continuous turns. One test was performed at a comfortable walking pace and the other at a fast pace. Approximately 5 minutes of rest was provided between trials. Then, participants walked through 2 other discontinuous courses (ie, pausing, stopping and/or obstacle negotiation), 1 of which simulated the home environment and the other consisted of negotiating obstacles (Fig. 2) . Each course was completed twice. The first was a practice trial to allow participants to become comfortable with the course. The data from the second trial was used in the analysis. In the event of incomplete transfer of data to reading device, invalid video recording, or incomplete syncing of information during any of the walking tasks, participants repeated that task up to 1 additional time.
For all trials, each participant wore 4 activity trackers on the less affected side of the body as determined by the Movement Disorders Society Unified Parkinson Disease Rating Scale, part III, motor score. The Fitbit Surge and Jawbone Up 2 were donned on the wrist, while the Fitbit Zip and Jawbone Up Move were donned to a gait belt on the participant's waist (Fig. 1 ). All activity trackers were worn in a manner that did not interfere with walking. Throughout all tasks, participants were supervised for safety by a licensed physical therapist while concurrently being video recorded by another member of the research team. Prior to the initiation of each trial, the starting number of steps on the activity tracker was established with the participant in a seated position. It was not possible to reset the activity tracker for each trial as they are designed to record steps on a 24-hour basis. Therefore, the total step number per trial was calculated as the difference between the starting and ending step counts for each individual trial. The method of obtaining the step count varied among the different brands. The Fitbit branded devices had a screen that readily displayed the total number of steps in real time. However, the Jawbone branded devices did not have a display screen. In order to visualize the step numbers on the Jawbone devices, a trained member of the research team used a device-specific iPad application, developed by Jawbone Incorporated, to determine the step counts for each trial. At the completion of each trial, all step counts were recorded.
Reference Standard
A research assistant videotaped the participants during all designated walking tasks. The reference standard of actual steps taken was determined by having 2 trained physical therapists independently count the number of steps on the video recording. 23 The physical therapists counted a movement as a step if there was any linear displacement of a single foot forwards, backwards, or sideways. 24 If agreement was not reached between the 2 independent evaluators, this process was repeated until consensus was reached.
Data Analysis
For each trial, a Bland-Altman plot was produced as an initial visualization and descriptive analysis. The Bland-Altman plot visually represents the difference between actual steps taken and steps recorded on the activity tracker plotted against the average steps obtained by the 2 methods. The solid horizontal line represents the mean difference between actual steps and recorded steps for that individual tracker. Two additional dotted lines indicate the 95% limits of agreement around the mean to assist in the evaluation of any outliers.
Prior to closing recruitment, the Bland-Altman plots were also used to compute minimum sample size requirements. 25 By choosing an optimally sized 95% confidence interval about the limits of agreement, a sample-driven conservative estimate for standard deviation across step differences was used to determine the number of participants that would be required. Based on this, a minimum of 30 participants was needed to secure limits of agreement accurate to within a 6-step-differential error margin using an estimated standard deviation of 10.
The ICC(2,1) was computed as a measure of agreement between actual steps taken and steps recorded by the tracker for each trial using SPSS statistics (IBM, version 20.0). Mean differences between the activity tracker and reference step counts were calculated. These differences are reported as negative values, as the activity tracker underrepresented the true step count. Mean absolute percent error was calculated as the absolute value of the difference in actual step count compared to reference step count for each trial. 9 Prior to all data analyses, trials that recorded zero values despite repeating the trial a second time were removed. These zero values were unlikely related to the accuracy of the devices themselves but may have been influenced by our wireless internet signal hindering Bluetooth syncing with the Apple iPad.
Results
A total of 33 people participated in this study. Data from all 33 participants was analyzed for all 4 tasks with the exception of 5 trials with zero values, which were removed (1 trial with the Jawbone Up Move during the 2-minute walk test at a fast pace and 4 trials with the Jawbone Up Move on the household obstacle course). There was also an episode of videography failure resulting in no reference data for a participant across 1 task. The total number of participants included in the analysis for each condition is reported in Table 1 . The participants had mild to moderate PD, their mean age was 65 years, and 58% were men. Two participants used assistive devices in the community; however, all study procedures were conducted without an assistive device. Fourteen individuals reported instances of freezing at least 1x/month and 7 participants reported falling in the last month (Tab. 2).
Overall, the most accurate device across all tasks was the Fitbit Zip, while the least accurate across all tasks was the Jawbone Up Move during the simulated household course. The ICCs for all of the activity trackers across all tasks ranged from −0.03 to 0.98 (Tab. 1). Mean absolute percent error ranged from .9%-67.3% across all activity Household course: Participants stood from a chair wearing a coat and walked to a coat rack where they took off and hung up the coat, followed by walking to a sink where they washed their hands and dried them. They threw out the paper towel and then walked to a low table where they picked up a full glass of water and set it down on a second table. Finally, they opened a door, walked through the doorway, and sat down in a chair. Obstacle Negotiation course: Participants stood from a chair and negotiated around 3 chairs, stepped over 2 shoe boxes, completed 2 turns of 90°, walked over a ~10 feet of yoga mat, stepped onto and over a 6 inch step, and then sat back down.
trackers and tasks (Fig. 3) . With regard to continuous walking tasks (2-minute walk tests at comfortable and fast speeds), the Fitbit Zip showed the highest accuracy, followed by the Jawbone Up Move, the Fitbit Surge, and lastly, the Jawbone Up 2. During the discontinuous tasks (both the household course and the obstacle negotiation course), all devices demonstrated compromised accuracy. However, when ranking these devices, the greatest accuracy was seen in the Fitbit Zip on these courses, followed by the Fitbit Surge, Jawbone Up 2, and finally, the Jawbone Up Move.
Walking Tasks: 2-Minute Walk Test at a Comfortable Speed
During the 2-minute walk test at a comfortable speed, the Fitbit Zip was the most accurate [ICC(2,1) = 0.98; 95% CI = 0.96 to 0.99]. The mean difference between the actual number of steps and the number of steps displayed on the activity tracker was −0.19 step, with an average of 230.81 steps taken for the task overall. The mean difference is reported as a negative because the activity tracker underrepresented the true step count. The Jawbone Up 2 was the least accurate [ICC(2,1) = 0.10; 95% CI = −0.26 to 0.43], with a mean difference between the actual number of steps and steps displayed on the tracker of −4. Bland-Altman plots (Fig. 4 and supplemental materials available at https://academic.oup. com/ptj) revealed that the wrist-mounted devices underrepresented the true step counts while the waist-mounted devices had a more evenly distributed pattern of error.
Walking Tasks: 2-Minute Walk Test at a Fast Speed
During the 2-minute walk test at a fast speed, the Fitbit Zip was the most accurate activity tracker [ICC(2,1) = 0.90; 95% CI = 0.81 to 0.95]. The mean difference between actual number of steps and number of steps displayed on the activity tracker was −2.15 steps, with an average of 259.64 steps taken for the task overall. The Jawbone Up 2 was the least accurate [ICC(2,1) = −0.02; 95% CI = −0.35 to 0.32], with a mean difference between actual number of steps and steps displayed on the tracker of −7.56. Visually, Bland-Altman plots (supplemental materials (available at https:// academic.oup.com/ptj)) revealed a larger variability in step counts for the wrist-mounted devices as compared to the waist-mounted devices. 
Obstacle Negotiation Course
During the obstacle negotiation course, Visually, Bland-Altman plots (supplemental materials (available at https:// academic.oup.com/ptj)) showed that the worst performing device ( Jawbone Up Move) was also the device that underrepresented steps by the largest amount.
Discussion
The purpose of this study was to investigate the accuracy of 4 consumer-grade activity trackers (Fitbit Zip, Fitbit Surge, Jawbone Up Move, Jawbone Up 2) in individuals with PD under a variety of walking conditions. It was hypothesized that the accuracy of the trackers may differ among the various devices and that accuracy may be influenced based on location worn (waist vs wrist) and type of walking task (continuous vs discontinuous).
Consistent with our hypotheses, the accuracy of step counts varied depending on the type of activity tracker (Fitbit Zip, Fitbit Surge, Jawbone Up Move, Jawbone Up 2), the task (2-minute walk comfortable and fast, household and obstacle negotiation courses), and the location worn (waist or wrist). The most accurate activity tracker was the Fitbit Zip (worn on waist) during continuous walking tasks. All 4 activity trackers demonstrated the highest accuracy with continuous walking tasks and the lowest accuracy with the household course task. In general, a waist-mounted device was the most accurate across both continuous and discontinuous courses, which is consistent with results of studies in healthy young adults, older adults, and in those with neurological conditions. 9, 11, 13, 26 There was a general trend for increased accuracy amongst all activity trackers for continuous walking compared to discontinuous walking. The sensitivity of the accelerometers may not be high enough to accurately detect steps in environments with greater discontinuity, where starting, stopping, and turning occur frequently. During continuous walking, persons with PD may demonstrate longer, more symmetrical step lengths compared to smaller, slower, shuffling steps with discontinuous walking. This difference may lead to lower accuracy while walking in environments requiring discontinuous walking behavior. This is consistent with data in persons with musculoskeletal and neuromuscular conditions in an inpatient rehabilitation facility where consumer-grade activity trackers were less accurate under conditions in which stride lengths were shorter. 27 It is also possible that individuals walked slower during the discontinuous walking course and these slower speeds might not exceed the minimum acceleration threshold necessary to register as a step on the activity trackers. 14,27 Although we did not specifically measure gait speed during the household and obstacle negotiation courses, it has been previously reported that slower walking speeds in community-dwelling people with stroke and traumatic brain injury contributes to decreased accuracy of activity trackers. 13, 14 The Bland-Altman plot and 95% limits of agreement also revealed a trend for increased accuracy of the waistmounted devices compared to the trackers placed on the wrist for continuous courses. This may be due to the fact that waist-mounted devices are closer to the individual's center of mass, thereby more accurately measuring acceleration. Wrist-worn devices could be influenced by tremor, dyskinesia, extraneous upper extremity movement generated during activities of daily living, or when gesturing with the upper extremities. Another source of error, specific to persons with PD, may be reduced arm swing, which could reduce the accuracy of wristbased devices. Our results are consistent with the findings in people with traumatic brain injury and stroke, which revealed greater accuracy in waist-worn trackers as compared to wrist-worn in the 2-minute walk test. 13 The trackers worn on the waist in the present study demonstrated higher ICCs than reported by Fulk and colleagues 13 (0.98 compared to 0.73, respectively), possibly due to faster walking speeds among our participants with PD compared to those with stroke and traumatic brain injury. Conversely, our results with wrist-worn trackers in PD reveal less agreement Mean absolute percent error for each of the activity trackers across the 2-min walk test (2MWT) at a comfortable speed, the 2MWT at a fast speed, the obstacle negotiation course, and the household course.
(ICC of 0.1 compared to 0.2) compared with those with stroke and traumatic brain injury. 13 Participants in both studies wore the tracker on the less involved wrist, however, the difference may be due to the bilateral decrease in arm swing in PD versus the predominantly unilateral decrease in arm swing in people post stroke.
It is visually depicted in the BlandAltman plots that all devices underrepresented the true step counts with the exception of the waist-mounted devices on the 2-minute walk test at a comfortable speed that was relatively accurate. Previous research examining the accuracy of Fitbit and Jawbone devices in people who were healthy also reported a general underestimation of steps, with mean absolute percent errors ranging between approximately 0% to 10% when completing continuous and discontinuous walking tasks in a laboratory-based setting. 9 In the present study, the mean absolute percent error ranged from 0.9% to 9.7% during continuous walking in people with PD. However, during discontinuous walking, the mean absolute percent error ranged from 7.1% to 67.3%, indicating greater variation in error rates compared with people who were healthy. The ICCs for persons with PD (-0.03 to 0.98) are lower than what is found in healthy populations (0.8 to 0.99) and more similar to the values derived in individuals with other neurologic conditions (0.19 to 0.97) when tested in multiple different settings, including both laboratory based and free-living environments. [10] [11] [12] [13] The algorithms in the various devices may underestimate step counts in persons with PD, as they do not take into account the poverty of movement and shortened step length and, therefore, may not register steps under these conditions. Furthermore, reduced acceleration of the limb, particularly under conditions in which there was a slowed initiation of gait, may have contributed to an underestimation of steps counted.
Another factor contributing to the misrepresentation of step counts across devices may be the presence of freezing of gait. Specifically, freezing may cause under representation of step counts as frequent pausing may retard the function of the accelerometers. While our sample size is not large enough to examine the influence of various characteristics of PD gait (ie, freezing, festination) on the accuracy of step counts, data from individual participants provides some insight. For example, in 1 participant who demonstrated freezing of gait in both the household and the obstacle negotiation course, a 60% error was observed across all devices in the household course and a 20% error across all devices in the obstacle negotiation course. In general, the magnitude of this error exceeded that observed among nonfreezers.
Study limitations include the relatively short duration of walking that occurred among the various tasks. In this study, participants engaged in 2-minute walk tests that ranged from 231 to 260 steps and simulated household and obstacle negotiation courses in which step counts ranged from 56 to 72 steps. Although 2-minute walk tests have been used to study the accuracy of activity trackers in other studies, 12,13 longer duration walking tests may result in reduced variability and higher levels of accuracy-particularly given the higher rates of accuracy we observed with more continuous walking. Jawbone activity trackers were required to sync via Bluetooth with an external device (an Apple iPad in this study). This additional step created greater risk for potential error due to the possibility of incomplete transmission for step-count data from the activity tracker to the iPad via Bluetooth. However, we refreshed the iPad multiple times in between trials in order to mitigate this effect. Finally, our sample population included patients with mild to moderate PD with an average walking speed of 1.26 m/s who are able to ambulate without the use of an assisted device. Results may not generalize to individuals with greater disease severity.
Increasing physical activity levels in those with PD is of great importance to physical therapists. Increasing walking behavior is one method of increasing physical activity in this population. Integrating activity trackers into a walking program may assist patients in this pursuit. Although this study revealed that step counts are generally underestimated in persons with PD, this primarily occurred under conditions where discontinuous stepping patterns were predominant, such as in the simulated home environment. Continuous ambulation was shown to have greater accuracy in estimating step counts (<10% absolute error), especially when waist-mounted trackers were worn (<2.6% absolute error). 9 The results of this study suggest that waist-monitored activity trackers, specifically the FitBit Zip, could be prescribed to monitor changes in continuous walking behavior in people with PD with reasonable accuracy. However, our results suggest that none of the 4 commercially available waist or wrist-based activity trackers investigated in this study are sufficiently accurate to monitor changes in walking in persons with PD under discontinuous conditions, such as in the home. Future research may include assessing accuracy of activity trackers over longer distances in real-world rather than simulated environments. Examining the accuracy of activity trackers in those with greater disease severity and in subpopulations with freezing, festinating gait, dyskinesia, and tremor is also warranted.
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